ID: ALA424606

Max Phase: Preclinical

Molecular Formula: C17H31N

Molecular Weight: 249.44

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC1(C)C2CC[C@]1(C)CN(CC1CCCCC1)C2

Standard InChI:  InChI=1S/C17H31N/c1-16(2)15-9-10-17(16,3)13-18(12-15)11-14-7-5-4-6-8-14/h14-15H,4-13H2,1-3H3/t15?,17-/m1/s1

Standard InChI Key:  OZWVJQQHNHWAKC-OMOCHNIRSA-N

Associated Targets(Human)

Sigma opioid receptor 6358 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 249.44Molecular Weight (Monoisotopic): 249.2456AlogP: 4.32#Rotatable Bonds: 2
Polar Surface Area: 3.24Molecular Species: BASEHBA: 1HBD: 0
#RO5 Violations: 0HBA (Lipinski): 1HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 11.09CX LogP: 4.39CX LogD: 1.10
Aromatic Rings: 0Heavy Atoms: 18QED Weighted: 0.70Np Likeness Score: 0.42

References

1. Yamashita A, Takahashi N, Mochizuki D, Tsujita R, Yamada S, Kawakubo H, Suzuki Y, Watanabe H.  (1997)  An aromatic moiety is not essential for pharmacophore binding to sigma binding sites: Synthesis of N-alkylazacycloheptane derivatives as potent sigma ligands,  (17): [10.1016/S0960-894X(97)00417-4]

Source